Table- 3.
P. aeruginosa gene expression in exposure to bile.
| Gene symbol | Function/presence | Regulation/Expression in response to bile | Technique | Bile/bile salt | Concentration | Strain | Ref. |
|---|---|---|---|---|---|---|---|
| mqoB | Glyoxylate shunt pathway | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| glcB | Glyoxylate shunt pathway | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| acnA | The early stage of the TCA cycle | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| idh | The early stage of the TCA cycle | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| PA0853-54 | The late stages of the TCA cycle | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| aspA | The late stages of the TCA cycle | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| lpdV | glucose metabolism/glycolysis | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| gapA | Glucose metabolism/glycolysis | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| glk | Glucose metabolism/glycolysis | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| aceEF | Glucose metabolism/glycolysis | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| pfm | Proton motive force | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| pqsA | Biofilm formation and virulence | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| pqsA-E | QS/biofilm formation and virulence | Increase | Promoter fusion and thin-layer chromatography | Bile | 0.30 % | PA14, PAO1 and clinical isolates CF242 | [27] |
| rhlI | Acyl-homoserine-lactone synthase | Increase | Promoter fusion and thin-layer chromatography | Bile | 0.30 % | PA14, PAO1 and clinical isolates CF242 | [27] |
| lasI | Acyl-homoserine-lactone synthase | Increase | Promoter fusion and thin-layer chromatography | Bile | 0.30 % | PA14, PAO1 and clinical isolates CF242 | [27] |
| psl | Biofilm formation and virulence | Increase | Congo red binding assay | Bile | 0.30 % | PAO1 | [50] |
| psrA |
Transcriptional regulator associated with biofilm formation |
Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| ppyR | Transcriptional regulator associated with iron-scavenging and exopolysaccharide production | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| ohrR | Transcriptional regulator associated with oxidative stress response | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| mexR | Transcriptional regulator associated with secretion and antibiotic tolerance | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| T3SS | Type III secretion systems (associated with acute infection) | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| T3SS effector exoU | Promoter activity of the T3SS effector exoU | 8.9- fold decrease | Real-time PCR | Bile | 0.30 % | PA14, PAO1 and clinical isolates CF242 | [27] |
| T6SS | Type vI secretion systems | Decrease | Real-time PCR | Bile | 0.30 % | PA14, PAO1 and clinical isolates CF242 | [27] |
| hcnABC | Hydrogen cyanide | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| amiR | Amidase | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| phzA-E | Phenazine | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| gnyR | Transcriptional regulator associated with isoprenoid degrading | Decrease | Real-time PCR | Bile | 0.30 % | UCBPP-PA14, PA14_38430 | [50] |
| sfa2 | Transcriptional regulator associated with T6SS HSI-II expression | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| mexAB-OprM | Efflux pump/Antibiotic tolerance | Increase | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| SiaA-D | Transition to a sessile lifestyle through cyclic-di-GMP synthesis | Upregulated | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |
| phzS | PYO biosynthetic genes | Increase | qRT-PCR | Bile | 0.30 % | PA14 | [31] |
| phzH | PYO biosynthetic genes | No significant response | qRT-PCR | Bile | 0.30 % | PA14 | [31] |
| phzM | PYO biosynthetic genes | No significant response | qRT-PCR | Bile | 0.30 % | PA14 | [31] |
| gdbR | Transcriptional regulator associated with choline | Decrease | Real-time PCR | Bile | 0.30 % | PAO1 | [50] |